Procyrion announced today that it appointed Andrew Davis as its new chief commercial officer (CCO), effective immediately. Houston-based Procyrion develops a catheter-deployed percutaneous mechanical circulatory support (pMCS) device called Aortix. The company designed the device to treat patients with acute decompensated heart failure (ADHF) … [Read more...] about Procyrion adds former Silk Road Medical exec as new CCO
Business
Xeltis secures $55.1M to support aXess commercialization
Xeltis announced today that it secured €47.5 million ($55.1 million) in financing to support its vascular access device. The funding includes €37.5m ($43.5 million) in funding from the EIB, supported under the European Commission’s Invest EU program, plus €10 million ($11.6 million) from existing investors, including EQT and … [Read more...] about Xeltis secures $55.1M to support aXess commercialization
Shifamed’s Akura Medical closes $53M Series C
Akura Medical, a Shifamed portfolio company, announced today that it completed the first close of its Series C financing, raising $53 million. Los Gatos, California-based Akura plans to use funds to support development activities for its Katana thrombectomy system and the NavIQ quantification software. It also aims to complete enrollment in its … [Read more...] about Shifamed’s Akura Medical closes $53M Series C
CMS adds reimbursement for cardiac ablation in ASCs
The Centers for Medicare and Medicaid Services (CMS) has provided a major reimbursement update for cardiac ablation technologies. In its 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule, CMS added cardiac catheter ablation procedures to its ASC-covered procedures list. This … [Read more...] about CMS adds reimbursement for cardiac ablation in ASCs
Okami Medical names former Inari CEO to corner office, raises $45M
Okami Medical announced today that it appointed a new CEO alongside the closing of an oversubscribed $45 million financing. Aliso Viejo, California-based Okami tapped Drew Hykes as its new president and CEO. It also appointed Bill Hoffman as chair of its board. Hykes previously served as the CEO of Inari Medical, a maker of solutions for … [Read more...] about Okami Medical names former Inari CEO to corner office, raises $45M
VenstraMedical picks up investment for ventricular assist device
VenstraMedical announced today that it secured an investment to accelerate the development of its percutaneous ventricular assist device (pVAD). Highcroft Capital, a Minnesota-based venture capital firm specializing in medtech innovation, delivered the undisclosed investment. It supports the Newcastle, Australia-based company’s low-profile, … [Read more...] about VenstraMedical picks up investment for ventricular assist device
Merit Medical to launch Wrapsody endoprosthesis in U.S. after CMS defers reimbursement decision
Merit Medical Systems (Nasdaq:MMSI) announced that its application for reimbursement for its Wrapsody procedures requires further CMS consideration. As a result, the company plans to go ahead with the U.S. rollout for the cell-impermeable endoprosthesis (CIE). "We have elected to withdraw our application for TPT incremental payment and intend … [Read more...] about Merit Medical to launch Wrapsody endoprosthesis in U.S. after CMS defers reimbursement decision
Boston Scientific, Siemens Healthineers ink 4D ICE catheter development deal
Boston Scientific [WtwhTicker symbol="BSX"](NYSE: BSX)[/WtwhTicker] today announced a catheter development and commercialization deal with Siemens Healthineers. The deal centers around the workflow development and commercialization of Siemens Healthineers' AcuNav 4D intracardiac echocardiography (ICE) catheter. AcuNav 4D ICE technology is … [Read more...] about Boston Scientific, Siemens Healthineers ink 4D ICE catheter development deal
Olympus issues label update for certain bronchoscopes related to endobronchial combustion
Olympus announced today that it made a voluntary corrective action to provide further clarification on the use of certain bronchoscopes. The company's global action aims to outline the safe and effective use of its bronchoscopes with laser therapy, argon plasma coagulation or high-frequency cauterization equipment during therapeutic procedures … [Read more...] about Olympus issues label update for certain bronchoscopes related to endobronchial combustion
CMS finalizes renal denervation coverage that benefits Medtronic, Recor
CMS today issued its final National Coverage Determination (NCD) on renal denervation (RDN), marking a major win for Medtronic [WtwhTicker symbol="MDT"](NYSE: MDT)[/WtwhTicker] and Recor Medical. Both companies develop their own RDN systems. Recor Medical received the first FDA nod for its Paradise ultrasound RDN (uRDN) system in November 2023. … [Read more...] about CMS finalizes renal denervation coverage that benefits Medtronic, Recor
